What factors drive the image-guided radiation therapy market?

The market will reach $3.3b by 2033.

Advancements in imaging technologies are propelling the global image-guided radiation therapy (IGRT) market to reach $3.3b by 2033 at a compound annual growth rate (CAGR) of 5.7%, according to Allied Market Research.

Key drivers include improvements in modalities such as MRI, CT, and PET to enhance the precision and accuracy of delivering radiation therapy.

“For instance, the integration of MRI-guided radiation therapy systems such as the ViewRay MRIdian system enables real-time visualisation of tumours during treatment, leading to improved outcomes,” the report said.

Meanwhile, the rising incidence of cancer and increasing demand for personalised medicine have fueled the adoption of IGRT as a preferred treatment modality due to its ability to tailor therapy based on an individual’s anatomy and specific tumour characteristics.

Furthermore, favourable reimbursement policies and government initiatives aimed at promoting advanced cancer treatment technologies have stimulated the sector’s growth.

These policies encourage healthcare facilities to invest in IGRT systems, increasing accessibility within the market.